Cerebrospinal fluid and brain positron emission tomography measures of synaptic vesicle glycoprotein 2A: Biomarkers of synaptic density in Alzheimer's disease. The gene discussed is SV2A; the disease is early-onset autosomal dominant Alzheimer disease.